Back to User profile » Professor Xiaojing Xing
Paper published by Professor Xiaojing Xing:
Clinical Trial Report
Phase 1b Multicenter Study of SG001, a Humanized Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors
Fang J, Jiang O, Li W, Lin J, Fang M, Li Q, Zhao W, Wang K, Shi H, Chen Z, Yu J, Xing X, Zhao M, Liu A, Wang W, Han Z, Xiang S, Zhang X, Li J, Zhou C
Drug Design, Development and Therapy 2025, 19:10423-10435
Published Date: 24 November 2025
